Reckitt Benckiser Group Plc 33.7% potential upside indicated by Barclays

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Reckitt Benckiser Group Plc with ticker (LON:RKT) now has a potential upside of 33.7% according to Barclays.



Barclays set a target price of 8,900 GBX for the company, which when compared to the Reckitt Benckiser Group Plc share price of 5,905 GBX at opening today (29/10/2021) indicates a potential upside of 33.7%. Trading has ranged between 5,367 (52 week low) and 7,192 (52 week high) with an average of 1,367,172 shares exchanging hands daily. The market capitalisation at the time of writing is £41,656,370,000.

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene, post-natal and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN). Health, Hygiene, Home and Portfolio Brands categories are split across the geographical segments of ENA and DVM. Its range of hygiene products includes disinfectant cleaners, automatic dishwashing detergents, pest control, depilatory products and acne treatments. The Company’s portfolio of brands includes Durex, Mucinex, Scholl, Strepsils, Cillit Bang, Clearasil, Dettol, Harpic, Lysol, Mortein, Veet, Air Wick, Calgon, Queen V, Vanish and Woolite.



Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Reckitt Benckiser Group PLC (LON:RKT) reports Q1 2024 results. Hygiene net revenue up 7.1%, Health up 1.0%, Nutrition down 9.9%. On track for full year delivery.
    Reckitt Benckiser Group PLC (LON:RKT) has released its final results for 2023, showing positive growth in Hygiene and Health sectors. CEO Kris Licht looks ahead to continued progress in 2024.

      Search

      Search